Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Awet Abraha

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Virology|June 29, 2004
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypesTatsuyoshi Kawamura, Shannon E Bruse, Awet Abraha, et al.
Journal of Virology|January 18, 2008
Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replicationYong Gao, Michael A Lobritz, Justin Roth, et al.
AIDS Research and Human Retroviruses|May 26, 2004
High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1Nathalie Richard, Marisa Juntilla, Awet Abraha, et al.
Journal of Virology|March 20, 2009
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemicAwet Abraha, Immaculate L Nankya, Richard Gibson, et al.
Journal of Virology|July 5, 2005
Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progressionRyan M Troyer, Kalonji R Collins, Awet Abraha, et al.
Journal of Virology|December 28, 2002
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and CSarah C Ball, Awet Abraha, Kalonji R Collins, et al.
Plos Pathogens|April 4, 2009
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) responseRyan M Troyer, John McNevin, Yi Liu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Virology|June 29, 2004
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypesTatsuyoshi Kawamura, Shannon E Bruse, Awet Abraha, et al.
Journal of Virology|January 18, 2008
Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replicationYong Gao, Michael A Lobritz, Justin Roth, et al.
AIDS Research and Human Retroviruses|May 26, 2004
High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1Nathalie Richard, Marisa Juntilla, Awet Abraha, et al.
Journal of Virology|March 20, 2009
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemicAwet Abraha, Immaculate L Nankya, Richard Gibson, et al.
Journal of Virology|July 5, 2005
Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progressionRyan M Troyer, Kalonji R Collins, Awet Abraha, et al.
Journal of Virology|December 28, 2002
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and CSarah C Ball, Awet Abraha, Kalonji R Collins, et al.
Plos Pathogens|April 4, 2009
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) responseRyan M Troyer, John McNevin, Yi Liu, et al.
Pageof 2